24-Jul-2019

Scientists at ETH Zurich and the South African company Strait Access Technologies are using 3D printing to produce custom-made artificial heart valves from silicone. This could help meet an ageing population’s growing demand for replacement heart valves. The human heart has four chambers, each ...

more

New, promising imaging technique for cardiac arrhythmias

23-Feb-2018

Every five minutes in Germany alone, a person dies of sudden cardiac arrest or fibrillation, the most common cause of death worldwide. This is partly due to the fact that doctors still do not fully understand exactly what goes on in the heart during the occurrence. Until now, it was impossible to ...

more

Stable, self-disrupting microbubbles as intravenous oxygen carriers

24-Jan-2018

Severe oxygen deficiency eventually leads to cardiac arrest. If the blood’s oxygen content cannot be rapidly re-established, the patient may die within minutes. American scientists have introduced air-filled microbubbles that could be used as an intravenous oxygen carrier to increase the survival ...

more

12-Jan-2018

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury. The results are a step closer to the goal of ...

more

14-Sep-2017

In the largest transcriptome study to date, an international research team analysed the RNA of transplanted hearts and discovered a number of new risk factors for dilated cardiomyopathy and other heart conditions which could thus be recognised more easily in future. We know of many genes with ...

more

19-Jun-2017

Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease patients. The research, led by Prof. Jonathan ...

more

License agreement between Georg-August-Universität Göttingen and Repairon GmbH

25-Apr-2017

MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart failure repair. ...

more

(V

24-Feb-2017

The human heart beats more than 2.5 billion times in an average lifetime. Now scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart's amazing biomechanical properties. "We created the I-Wire Heart-on-a-Chip so that we can understand why ...

more

07-Feb-2017

An anticancer agent in development promotes regeneration of damaged heart muscle - an unexpected research finding that may help prevent congestive heart failure in the future. Many parts of the body, such as blood cells and the lining of the gut, continuously renew throughout life. Others, such ...

more

Non-invasive alternative to catheter-based surgery

24-Jan-2017

At the GSI Helmholtz Center for Heavy Ion Research was developed and tested a new method for a future treatment of cardiac arrhythmia. The research was carried by a team of biophysicists from GSI and physicians from Heidelberg University and the Mayo Clinic in the United States. Beams of carbon ...

more